Trial Profile
Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2019
Price :
$35
*
At a glance
- Drugs Piflufolastat F18 (Primary)
- Indications Prostate cancer
- Focus Diagnostic use; Pharmacokinetics
- 12 Feb 2019 Status changed from recruiting to completed.
- 03 Oct 2017 Status changed from not yet recruiting to recruiting.
- 24 Apr 2017 Planned initiation date changed from 1 Mar 2017 to 1 Jul 2017.